Showing results (11-20 of 65) with videos related to
Sort By:
Pageof 7
Molecular Immunology|October 9, 2009
Kinetics and thermodynamics of interaction of coagulation factor VIII with a pathogenic human antibodyJordan D Dimitrov, Lubka T Roumenina, Sebastien Andre, et al.Blood|October 24, 2002
CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia AMarc Jacquemin, Valérie Vantomme, Cécile Buhot, et al.Clinical Therapeutics|July 20, 2010
Tolerability and pharmacokinetics of TB-402 in healthy male volunteersPeter Verhamme, Steve Pakola, Thomas J Jensen, et al.Frontiers in Immunology|July 24, 2018
Corrigendum: Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse ModelElin Malek Abrahimians, Luc Vander Elst, Vincent A Carlier, et al.Frontiers in Immunology|March 15, 2016
Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse ModelElin Malek Abrahimians, Luc Vander Elst, Vincent A Carlier, et al.Human Gene Therapy|December 30, 2015
Suppression of Immune Response to Adenovirus Serotype 5 Vector by Immunization with Peptides Containing an MHC Class II Epitope and a Thio-Oxidoreductase MotifWei Miao, Roxana Roohi Ahangarani, Vincent Carlier, et al.The Journal of Biological Chemistry|May 16, 2002
Low molecular weight peptides restore the procoagulant activity of factor VIII in the presence of the potent inhibitor antibody ESH8Sylvie Villard, Dominique Piquer, Sanjee Raut, et al.Haematologica|January 2, 2008
Factor VIII bypasses CD91/LRP for endocytosis by dendritic cells leading to T-cell activationSuryasarathi Dasgupta, Ana Maria Navarrete, Sebastien André, et al.Blood|September 21, 2006
VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectorsSuryasarathi Dasgupta, Yohann Repessé, Jagadeesh Bayry, et al.Pageof 7